Phase 1 Aggressive NK-cell Leukemia Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Aggressive NK-cell LeukemiaLGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell Lymphoma+10 more

Dren Bio200 enrolled37 locationsNCT05475925

Recruiting

Phase 1Phase 2

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

Aggressive NK-cell Leukemia

Hiroshima University Hospital7 enrolled1 locationNCT05863234